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Abstract 
A high-fat (HF) diet alters gut microbiota and promotes obesity related infammation and cognitive 
impairment. Teasaponin is the major active component of tea, and has been associated with 
antiinfammatory efects and improved microbiota composition. However, the potential protective efects of 
teasaponin, against HF diet-induced obesity and its associated alteration of gut microbiota, infammation 
and cognitive decline have not been studied. In this study, obesity was induced in C57BL/6J male mice by 
feeding a HF diet for 8 weeks, followed by treatment with oral teasaponin (0.5%) mixed in HF diet for a 
further 6 weeks. Teasaponin treatment prevented the HF diet-induced recognition memory impairment 
and improved neuroinfammation, gliosis and brain-derived neurotrophic factor (BDNF) defcits in the 
hippocampus. Furthermore, teasaponin attenuated the HF diet-induced endotoxemia, pro-infammatory 
macrophage accumulation in the colon and gut microbiota alterations. Teasaponin also improved glucose 
tolerance and reduced body weight gain in HF diet-induced obese mice. The behavioral and 
neurochemical improvements suggest that teasaponin could limit unfavorable gut microbiota alterations 
and cognitive decline in HF diet-induced obesity. 
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Dietary teasaponin ameliorates 
alteration of gut microbiota and 
cognitive decline in diet-induced 
obese mice
Sen Wang1,2, Xu-Feng Huang  1,3, Peng Zhang1,3, Kelly A. Newell1, Hongqin Wang1, Kuiyang 
Zheng3 & Yinghua Yu1,3
A high-fat (HF) diet alters gut microbiota and promotes obesity related inflammation and cognitive 
impairment. Teasaponin is the major active component of tea, and has been associated with anti-
inflammatory effects and improved microbiota composition. However, the potential protective 
effects of teasaponin, against HF diet-induced obesity and its associated alteration of gut microbiota, 
inflammation and cognitive decline have not been studied. In this study, obesity was induced in 
C57BL/6 J male mice by feeding a HF diet for 8 weeks, followed by treatment with oral teasaponin 
(0.5%) mixed in HF diet for a further 6 weeks. Teasaponin treatment prevented the HF diet-induced 
recognition memory impairment and improved neuroinflammation, gliosis and brain-derived 
neurotrophic factor (BDNF) deficits in the hippocampus. Furthermore, teasaponin attenuated the 
HF diet-induced endotoxemia, pro-inflammatory macrophage accumulation in the colon and gut 
microbiota alterations. Teasaponin also improved glucose tolerance and reduced body weight gain in 
HF diet-induced obese mice. The behavioral and neurochemical improvements suggest that teasaponin 
could limit unfavorable gut microbiota alterations and cognitive decline in HF diet-induced obesity.
Obesity increases the incidence of insulin resistance, type 2 diabetes, and cognitive decline in neurodegenera-
tive diseases such as vascular dementia and Alzheimer’s disease (AD)1,2. Obesity is characterized by low grade 
systemic inflammation, which is associated with an alteration of gut microbiota and brain function3. Empirical 
evidence has linked a high-fat (HF) diet with alterations of gut microbiota4 and impairments in cognition, includ-
ing a decline in recognition memory in both animal and human studies5,6. The hippocampus plays an impor-
tant role in improving recognition memory7–9. Lesions in the hippocampus severely disrupt object recognition7, 
object-in-place memory10, and temporal order recognition memory11 in rodent studies.
Previous studies have provided compelling evidence to suggest an association between the gut microbiota, 
HF diet and body weight regulation4,12. Firmicutes and Bacteriodetes account for more than 90% of the total 
gut microbiota13. An 8-week HF diet increased Firmicutes and reduced Bacteriodetes in mice4. Consistent 
with animal models, a similar difference of an increased ratio of Firmicutes/Bacteroidetes in the gut microbi-
ota has also been reported in obese humans14. Moreover, increased fat intake has been strongly correlated with 
increased plasma lipopolysaccharide (LPS), the endotoxin which is a major component of the outer membrane in 
Gram-negative bacteria10. In HF diet-induced obesity, endotoxemia has been linked with alterations of gut micro-
biota and increased intestinal permeability11. Currently, obesity and the related cognitive decline are associated 
with microbiota alterations and low-grade systemic and central inflammation9,10, which contribute to interrup-
tion of the gut-brain axis3.
It is known that endotoxemia can trigger systemic inflammation including neuroinflammation, and cog-
nitive impairment15. For example, systemic LPS administration activated microglia and increased expression 
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of pro-inflammatory factors in the hippocampus of mice16. Microglia and astrocytes are the principal immune 
cells in the central nervous system (CNS). The activation of microglia promotes the release of pro-inflammatory 
cytokines, which contribute to the neurodegenerative process15. Microglia and astrocytes express numerous 
members of the Toll-like receptor (TLR) family17, which recognize conserved microbial motifs expressed by a 
wide array of pathogens. For example, LPS binds to TLR4 mediated by myeloid differentiation primary-response 
protein 88 (MyD88), and activates c-Jun N-terminal kinase (JNK) and nuclear factor-kappa B (NFκB), two 
important inflammatory signaling molecules17. The activation of the TLR4-MyD88-JNK/NFκB signaling path-
way leads to the production of pro-inflammatory cytokines, such as interleukin-1β (IL-1β), interleukin-6 (IL-6), 
and tumor necrosis factor-α (TNF-α), and contributes to the development of neurodegenerative diseases18–21. 
Adult hippocampal neurogenesis and its related learning and memory are influenced negatively by microglial 
activation and neuroinflammation18. Furthermore, intestinal microbiota affect central levels of brain-derived 
neurotropic factor (BDNF) and cognitive behavior. Administration of oral antimicrobials to SPF mice transiently 
alter the composition of intestinal microbiota and increase hippocampal expression of BDNF19.
Tea has been cultivated for thousands of years and used for beverage and medicinal purposes. Previous studies 
have found tea can prevent obesity and abnormal glucose and lipid metabolism20. Recently, research on tea has 
shown it possesses anti-inflammatory properties, and improves microbiota and cognition21–25. Phenolics and 
saponin are the two major active components of tea extract. Most research to date has focused on the interaction 
of dietary polyphenols and intestinal microbiota26–28. However, the effects of teasaponin on the modulation of 
the intestinal microbiota and cognition remain poorly investigated and understood. This study used a chronic 
HF diet-induced obese mouse model to assess the ability of dietary teasponin to regulate the gut-brain axis and 
ultimately prevent cognitive impairment, glucose intolerance and body weight gain. The gut microbiota, endo-
toxinemia, colonic macrophage shift, hippocampal inflammation and gliosis, recognition memory, body weight 
gain, and glucose tolerance were examined in these mice.
Results
Teasaponin reversed the alteration of gut microbiota and systemic inflammation induced by a 
HF diet in obese mice. To investigate the effect of high-fat diet on intestinal microbiota and whether teasap-
onin could reverse this effect, qRT-PCR was used to evaluate the abundance of several vital species of gut flora in 
the cecal content, including Bacteroides-Prevotella spp., Desulfovibrios spp., Bifidobacterium spp. and Lactobacillus 
spp. The HF diet significantly decreased the amount of Bacteroides-Prevotella spp. (p = 0.016) and Desulfovibrios 
spp. DNA (p < 0.001), and increased Bifidobacterium spp. (p = 0.002) and Lactobacillus spp. DNA (p = 0.001) 
compared with the control mice (Fig. 1A). A 6-week teasaponin oral treatment prevented the alteration of gut 
Figure 1. (A) Bacteroides-Prevotella, Desulfovibrios, Bifidobacterium and Lactobacillus DNA expressions in 
gut microbiota of the control group (Con), high-fat diet group (HF), and HF with teasaponin treatment group 
(HF + TS) (n = 12 per group). *p < 0.05 compared to the Con group, #p < 0.05 compared to the HF group, 
values are means ± SEM. (B) The plasma LPS level of control group (Con), high-fat diet group (HF), and HF 
with teasaponin treatment group (HF + TS) (n = 12 per group).
www.nature.com/scientificreports/
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microbiota induced by the HF diet. The amount of Bacteroides-Prevotella spp. DNA and Desulfovibrios spp. DNA 
were significantly increased in the HF + TS group compared to the HF group (p = 0.007, p = 0.013 respectively). 
The amount of Bacteroides-Prevotella spp. DNA in the HF + TS group was similar to the control mice (p = 0.488), 
while the amount of Desulfovibrios spp. DNA in the HF + TS group was still significantly lower than the con-
trol mice (p < 0.001). Meanwhile, the teasaponin treatment also prevented the HF diet-induced alteration of the 
amount of Bifidobacterium spp. DNA (p = 0.003) and Lactobacillus spp. DNA (p = 0.001) in the HF + TS group 
compared to the HF group. There was no statistical difference between the HF + TS group and the control group 
in Lactobacillus spp. DNA (p = 0.992) and Bifidobacterium spp. DNA (p = 0.701) (Fig. 1A).
To further determine whether teasaponin also decreased systemic inflammation with improving gut microbi-
ota, the plasma concentration of LPS was measured. Teasaponin prevented an increase of plasma LPS induced by 
the HF diet after the 6-week treatment (Control: 0.66 ± 0.03 EU/ml, HF: 1.05 ± 0.08 EU/ml, HF + TS: 0.67 ± 0.04 
EU/ml, p = 0.001). There was no difference between the control and the HF + TS groups in the plasma LPS con-
centrations (p = 0.805) (Fig. 1B).
Teasaponin reduced M1 macrophage accumulation in the colon of HF diet-induced obese 
mice. To investigate the effect of teasaponin on macrophage accumulation in the colon of HF diet-induced 
obese mice, macrophages were stained with F4/80 antibody. The positive immunoreactivity of F4/80 was signif-
icantly increased in the colon of obese mice (p < 0.001), while it was ameliorated by the teasaponin treatment 
(p < 0.001) (Fig. 2A and B). Furthermore, the types of macrophages were characterized. CD11c was used to detect 
Figure 2. The expression of F4/80, CD11c, and CD206 macrophages in the colon. (A) Immunohistochemical 
staining, scale bar = 100 μm. (B) Quantification of the F4/80, CD11c, and CD206-positive areas (%). *p < 0.05 
compared to the Con group, #p < 0.05 compared to the HF group, values are means ± SEM.
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M1 macrophages, which produce pro-inflammatory cytokines, and CD206 was used to detect M2 macrophages 
which produce anti-inflammatory cytokines. Teasaponin significantly reduced the CD11c positive staining 
(p < 0.001), but there was no significant difference in the CD206 staining of the colon among the control group, 
the HF group and the HF + TS group (Fig. 2A and B).
Teasaponin suppressed the hippocampal inflammation in HF diet-induced obese mice. To 
investigate whether LPS (endotoxemia) could be related to hippocampal inflammation, the TLR4-My88-NFκB/
JNK signaling pathway and pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β) were examined in hippocampal 
tissue. Western blotting revealed that the TLR4 (p = 0.036) and MyD88 (p < 0.001) levels in the hippocampus 
were significantly higher in the HF group than the control group. The TLR4 and MyD88 levels were significantly 
lower in the HF + TS group compared to the HF group (p = 0.032, p < 0.001 respectively), with the teasaponin 
treatment restoring the TLR4 and MyD88 levels to control levels (Fig. 3). Furthermore, the p-JNK (p < 0.001) 
and NFκB (p = 0.005) levels were significantly higher in the HF group compared to the control group, while 
the teasaponin treatment prevented an increase of p-JNK and NFκB (p < 0.001, p = 0.008) (Fig. 3). Levels of 
pro-inflammatory cytokines, IL-1β (p = 0.015), IL-6 (p = 0.006) and TNF-α (p = 0.009) were significantly higher 
in the HF group compared to the control group (Fig. 3). Teasaponin significantly decreased IL-1β (p = 0.003) and 
IL-6 (p = 0.015) levels compared to the HF group, with the HF + TS group showing no difference in IL-1β and 
IL-6 levels compared the control group.
Teasaponin ameliorated microglial and astrocyte accumulation in the hippocampus of HF 
diet-induced obese mice. Activation, recruitment, and proliferation of microglia and astrocytes are hall-
marks of the brain response to neuronal injury. We therefore assessed the expression of a microglial cell-specific 
marker, Iba-1 and an astrocyte activation marker, GFAP, in the hippocampus to investigate the effects of a HF 
diet on inflammatory responses and to examine whether teasaponin mitigates the activation and infiltration 
of glial cells in the brain. Immunohistochemistry revealed the number of hippocampal microglia in the HF 
group increased nearly 50% compared to the control group (p < 0.001), while teasaponin significantly ame-
liorated microglial accumulation in the hippocampus of high-fat diet-induced obese mice after 6 weeks treat-
ment (p < 0.001) (Fig. 4). Microglial number in the HF + TS group was similar to the control group (p = 0.214). 
Meanwhile, the HF diet increased the number of astrocytes in the hippocampus of obese mice by nearly 25% 
compared to the control mice fed lab chow (p = 0.002). Teasaponin, to some degree, ameliorated astrocyte accu-
mulation in the hippocampus of the HF group, but there was no statistical difference (p = 0.147). The number of 
astrocytes in the hippocampus of the HF + TS group was still higher than the control group (p = 0.044) (Fig. 5).
Teasaponin improved recognition memory and increased BDNF levels in the hippocampus of 
HF diet-induced obese mice. To assess whether teasaponin treatment can prevent HF diet-induced rec-
ognition memory deficits, we performed a novel object recognition test in mice. During the training session of 
the test, there was no significant difference in the percentage of time spent exploring the objects in the open-field 
among the control group, the HF group and the HF + TS group (p > 0.05). During the retention session, HF mice 
Figure 3. Protein expression levels of TLR4, MyD88, p-JNK, NFκB, IL-1β, IL-6, and TNF-α in the 
hippocampus of the control group (Con), high-fat diet group (HF), and HF with teasaponin treatment group 
(HF + TS) (n = 12 per group). *p < 0.05 compared to the Con group, #p < 0.05 compared to the HF group, 
values are means ± SEM.
www.nature.com/scientificreports/
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showed reduced novel object exploration compared to controls, while the teasaponin treatment restored this to 
control levels (Control: 33.84 ± 2.58 seconds, HF: 28.25 ± 1.55 seconds, HF + TS: 34.36 ± 2.57 seconds, p = 0.001) 
(Fig. 6A). The discrimination index was further analyzed to assess recognition memory. The HF diet decreased 
the discrimination index by 58.62% compared to the control group (p < 0.001), while the teasaponin treatment 
increased the discrimination index by 133.33% compared with the HF group (p < 0.001) without significant dif-
ference compared with control group (Fig. 6B). These results show that teasaponin treatment improved recogni-
tion memory deficits caused by a HF diet.
We then measured hippocampal BDNF levels, which are important for synaptic plasticity and learning and 
memory. Compared with the control group, the BDNF level of the HF group was significantly lower (p < 0.001) 
(Fig. 6C). Importantly, the teasaponin treatment significantly increased the BDNF level in the hippocampus of the 
HF + TS group compared to the HF group (p = 0.011), but the BDNF level in the HF + TS group was still lower 
(p < 0.001) than the control group (Fig. 6C). There was a significant positive correlation between the hippocam-
pal BDNF level and the discrimination index of the novel object recognition test (r = 0.845, p < 0.001) (Fig. 6D). 
Furthermore, the discrimination index was also positively correlated with Bacteroides-Prevotella spp. DNA in 
cecal contents (r = 0.853, p < 0.001) (Fig. 6E) and was negatively correlated with the plasma LPS level (r = −0.909, 
p < 0.001) (Fig. 6F).
Teasaponin reduced body weight and improved glucose tolerance in HF diet-induced obese 
mice. The body weight in HF groups was significantly higher than that of the control group (HF: 33.11 ± 2.41 g, 
Control: 25.80 ± 1.56 g, p < 0.05) after 8 weeks of HF diet (Fig. 7A). After one week of treatment, the teasaponin 
Figure 4. (A) Microglia accumulation in the hippocampus of the control group (Con), high-fat diet group 
(HF) and HF with teasaponin treatment group (HF + TS) shown at ×5 (A1-3), ×10 (A4-6) and ×40 (A7-9) 
magnification; Scale bar = 20 μm. (B) Relative percentage of No. microglia in the hippocampus (%). *p < 0.05 
compared to the Con group, #p < 0.05 compared to the HF group, values are means ± SEM.
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group began to show a decrease in body weight. After the teasaponin treatment for 6 weeks, the final body weight 
was significantly lower in the HF + TS group than the HF group (HF + TS: 31.32 ± 1.87 g, HF: 39.14 ± 3.67 g, 
p = 0.038), however the body weight in the HF + TS group remained higher than the control group (HF + TS: 
31.32 ± 1.87 g, Control: 27.33 ± 1.54 g, p < 0.001) (Fig. 7A). There was no difference in energy intake during the 
teasaponin treatment period between HF + TS and HF group (all p > 0.05) (Fig. 7B). Furthermore, teasaponin 
significantly improved glucose tolerance in the HF diet-induced obese mice (Fig. 7C). The fasting glucose level 
of the HF + TS group and the control group was significantly lower than the HF group (all p < 0.05), while there 
was no difference between the HF + TS group and the control group (p = 0.326). The blood glucose level of the 
teasaponin treatment group significantly decreased at 15, 30, 60, and 120 minutes compared with the HF group 
(all p < 0.05), but they were still higher than those of the control group (all p < 0.05).
Discussion
Our results show that a long-term teasaponin treatment improved gut microbiota, suppressed endotoxin in 
plasma, enhanced object recognition memory, inhibited hippocampal inflammation and gliosis, and increased 
BDNF in the hippocampus in HF diet fed mice. Previously, tea or derivative powders have been shown to improve 
fecal microbiota and have anti-inflammatory benefits in both human and animal studies21,22. Moreover, clinical 
and animal studies have shown that tea improved cognitive function and prevented impairment of learning and 
memory23–25. In the present study, treatment with teasaponin, an important active ingredient of tea, improved 
Figure 5. (A) Astrocyte accumulation in the hippocampus of the control group (Con), high-fat diet group 
(HF) and HF with teasaponin treatment group (HF + TS) shown at ×5 (A1-3), ×10 (A4-6) and ×40 (A7-9) 
magnification; Scale bar = 20 μm. (B) Relative percentage of No. astrocyte in the hippocampus (%). *p < 0.05 
compared to the Con group, #p < 0.05 compared to the HF group, values are means ± SEM.
www.nature.com/scientificreports/
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microbiota and enhanced memory for object recognition in HF diet fed mice. Therefore, the effect of teasaponin 
on manipulation of the gut microbiota may contribute to the ability of tea to improve cognitive function and 
memory.
Compelling evidence suggests there is an association between gut microbiota, HF diet and body weight regu-
lation4,12. The ratio of the two dominant gut phyla, Firmicutes and Bacteroidetes, increases with obesity in human 
studies and animal experiments4,14,29. A HF diet for 8 weeks post-weaning has been shown to change the micro-
biota, decrease the overall bacterial abundance, and increase the ratio of Firmicutes to Bacteriodetes in mice4. 
Furthermore, alteration of gut microbiota induced by increased nutrient load has been directly correlated with 
Figure 6. The object exploration time (A) and the discrimination index (B) in the novel object recognition 
test of the control group (Con), high-fat diet group (HF) and HF with teasaponin treatment group (HF + TS). 
(C) The level of BDNF expression in the hippocampus of mice (n = 12 per group). The discrimination index 
in novel object recognition was positively correlated with BDNF in the hippocampus (D) and Bacteroides-
Prevotella spp. DNA in cecal contents (E), and was negatively correlated with plasma LPS (F). *p < 0.05 
compared to the Con group, #p < 0.05 compared to the HF group, values are means ± SEM.
www.nature.com/scientificreports/
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stool energy loss in lean individuals, as evidenced by an increase in Firmicutes and a decrease in Bacteroidetes 
which were associated with an increased energy harvest in subjects with a greater fractional decrease in stool 
energy loss12. In our study, we found that teasaponin prevented a HF diet induced alteration of microbiota at 
the species level, especially increasing Bacteroides-Prevotella spp. and decreasing Lactobacillus spp belonging to 
Bacteroidetes and Firmicutes respectively30. Overall these findings suggest that the prebiotic-like effects of teasap-
onin on microbiota may contribute to decreased energy accumulation and body weight gain with stool energy 
loss following improving microbiota.
In the present study, teasaponin treatment alleviated the hyper-endotoxemia in HF diet-induce obese mice. 
Previously, the plasma LPS level was closely correlated with changes in the Gram-negative Bacteroides-like 
intestinal bacteria that reside within the Bacteroidetes phylum31. We found elevated plasma LPS and decreased 
Gram-negative bacterium Bacteroides-Prevotella spp. and Desulfovibrios spp. DNA levels in HF diet-induced 
obese mice. An elevated plasma LPS level has been related to the over-production of LPS in the gut by the death of 
Gram-negative bacteria and their translocation into the bloodstream via an increased intestinal permeability in 
HF diet-induced obesity32. Therefore, a reduction in Gram-negative bacterium, as observed in the present study, 
may over-release LPS leading to hyperendotoxemia in the HF diet-induced obese mice. Importantly, dietary 
teasaponin decreased plasma LPS in these obese mice, perhaps by preventing the decrease of Gram-negative 
bacterium (including Bacteroides-Prevotella spp. and Desulfovibrios spp.) induced by a HF diet at the same 
Figure 7. Body weight (A), energy intake (B) and glucose tolerance (C) of the control group (Con), high-fat 
diet group (HF) and HF with teasaponin treatment group (HF + TS). *p < 0.05 compared to the Con group, 
#p < 0.05 compared to the HF group, values are means ± SEM.
www.nature.com/scientificreports/
9ScIEnTIfIc RepoRtS | 7: 12203  | DOI:10.1038/s41598-017-12156-2
time. These data strongly suggest that teasaponin affected the intestinal microbiota and was responsible for the 
attenuation of metabolic endotoxemia in HF diet-induced obesity. A HF diet has previously been shown to ele-
vate LPS levels in colonic fluid to activate pro-inflammatory cytokines (TNF-α, IL-6 and IL-1β) in the colon33. 
Our study showed that a chronic high-fat diet induced pro-inflammatory M1 macrophage accumulation in 
the colon of obese mice accompanied by increased levels of TNF-α, IL-6 and IL-1β, M1 macrophage produced 
pro-inflammatory cytokines34,35. Importantly, this present study shows that dietary teasaponin significantly ame-
liorated M1 macrophage accumulation in the colon of HF diet-induced obese mice.
We report that Lactobacillus spp. and Bifidobacterium spp. were increased and Desulfovibrios spp. was 
decreased following a HF diet. While Desulfovibrios spp. has been found to be increased in a previous study of 
HF diet-induced obesity36, Lactobacillus spp. and Bifidobacterium spp have been reported to decrease following 
HF diet in rodents13,36–38. This contrast may be due to differences in food composition (percentage of fat, type of 
fatty acids or feeding period) or experimental methods (feeding HF diet or inoculating fresh feces from HF diet 
fed mice) between the studies. For example in P. D. Cani’s study, the HF diet contains 72% of the energy from fat 
which is higher than that used in our study (60%)37. In Kim’s study, inoculation with HF diet faeces resulted in a 
reduced number of Bifidobacteria colonies in mice13. Our finding of increased Lactobacillus spp in the gut micro-
biome of mice after HF diet, is consistent with a human study which reported a significantly higher concentration 
of Lactobacillus species in obese patients than in lean controls or anorexic patients39. Further, it was reported 
that specific Lactobacillus in human feces, such as Lactobacillus reuteri or Lactobacillus sakei, were positively 
correlated with body mass index in 263 individuals, including 134 obese, 38 overweight, 76 lean and 15 anorexic 
subjects40, proving support for an association between increased Lactobacilius and increased body weight. It 
is reported that Bifidobacterium spp is significantly increased in HF diet for 4 weeks in mice and ob/ob mice41, 
which is in agreement with our observations. Furthermore, many different species and strains of Lactobacillus 
spp and Bifidobacterium spp contribute to weight gain in infants. For example, Bifidobacterium lactis was sig-
nificantly associated with increased weight gain in infants born to mothers with HIV infection42. Lactobacillus 
acidophilus, Lactobacillus fermentum and Lactobacillus ingluviei administration significantly increases weight 
gain in infants43. Therefore, the role of different species or strain of Lactobacillus spp. and Bifidobacterium spp. in 
weight gain require further clarification.
Consistent with a previous study that teasaponin affects the rumen fermentation and increases microbial 
mass yield in vitro44, the present study showed that teasaponin affects gut microbiota in HF diet-induced obese 
mice. The exact mechanism underlying this is not clear, however, teasaponin improves the enzymatic hydrolysis 
of dietary fibre (such as glucan and lignin), which are microbiota-accessible carbohydrates45. Teasaponin can 
also be degraded by cellulolytic enzymes and release glucose, which could be utilized by microbiota to promote 
saccchrification and fermentation45.
Previously, systemic LPS administration activated microglia and increased expression of pro-inflammatory 
factors in the hippocampus of mice16. We found that HF diet induced hippocampal inflammation in obese mice 
with hyper-endotoxemia. Therefore, the systemic accumulation of toxins, induced by a HF diet may contribute to 
inflammation in the hippocampus. It has been reported that activated microglial cells release pro-inflammatory 
cytokines IL-1 and TNF-α, which contribute to the neurodegenerative process46. The activation of astrocytes is 
known to induce innate and adaptive immunity47 and astroglial responses were assessed in the present study by 
GFAP immunostaining. Our findings showed that HF diet promoted the expression of GFAP and Iba-1 in hip-
pocampus suggesting an excessive infiltration of glial cells and possible gliosis. Importantly, dietary teasaponin 
constrained the activation of Iba-1, but not GFAP, induced by the HF diet. It is known that astrocytes contain 
glycogen and are capable of glycogenesis. Therefore, teasaponin only inhibited the inflammatory response in 
microglia, but did not affect astrocytes in the hippocampus. Hippocampal inflammation is highly associated with 
recognition memory impairment48. In the present study, teasaponin significantly improved recognition mem-
ory in a novel object testing procedure with inhibition of microgliosis and inflammation in the hippocampus. 
Therefore, teasaponin, in preventing hyperendotoxemia and hippocampal inflammation, may contribute to rec-
ognition memory improvement.
TLR4 is the receptor for LPS and expressed in microglia, astrocytes and neurons49,59. Activation of TLR4 
signaling inhibits neurogenesis50, while deficiency of TLR4 dramatically ameliorates neuroinflammation in the 
hippocampus of C57BL/6 mice51. As a critical adapter protein for TLR4, MyD88 leads to an activation of down-
stream nuclear factor-κB (NFκB)/JNK and subsequent production of pro-inflammatory cytokines implicated 
in neurotoxicity52–54. In this study, dietary teasaponin prevented the activation of the TLR4-My88-JNK/NFκB 
inflammatory signaling pathway and an over-expression of pro-inflammatory cytokines in the hippocampus 
induced by a chronic HF diet. Previous studies have demonstrated that inflammation decreases the expression 
of BDNF in the rat hippocampus55,56 and reduced hippocampal BDNF is associated with recognition memory 
impairment; increasing hippocampal BDNF has been shown to improve recognition memory57. In the pres-
ent work, teasaponin increased BDNF levels in the hippocampus of obese mice, which may contribute to the 
improvement in recognition memory in these mice. Furthermore, in the present study, there was a significant 
positive correlation between the level of Bacteroides-Prevotella spp. and cognitive ability as measured by the dis-
crimination index in the novel object recognition test. Indeed, a recent study reports that infants with high levels 
of gut Bacteroides at 1 year of age show higher cognitive ability at 2 years old58. Overall, dietary teasaponin may 
improve microbiota-gut-brain function and cognition.
In conclusion, this study demonstrated that dietary teasaponin reinstalls gut microbiota, and reduces gut 
mucosal inflammation and hyperendotoxinemia in chronic HF diet-induced obese mice. These peripheral ben-
eficial effects are accompanied by a reduction of CNS hippocampal microglia activation, an increase of BDNF 
production, and an improvement of cognitive function in obese mice. The behavioral and neurochemical 
improvements suggest that teasaponin could be a promising strategy to improve gut-brain axis for the prevention 
of HF diet-induced obesity and associated cognitive decline. This study demonstrated the beneficial effect of 
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teasaponin on gut microbiota using qRT-PCR. To further characterize detailed changes of gut microbiota com-
position, future studies should use 16S rRNA sequencing or metagenomic sequencing. Furthermore, to elucidate 
the effects on the brain-gut axis, more candidate species of microbiota, which may be involved in processes such 
as amyloid secreting, γ-aminobutyric acid biosynthesis, short-chain fatty acids biosynthesis, histone deacetylation 
(HDAC) and G-protein-coupled receptors, should be analysed.
Methods
Animals and treatments. Thirty-six C57BL/6 J male mice (8 weeks old) were purchased from the 
Australian Bio-Resource Centre (Moss Vale, NSW), and housed in environmentally controlled conditions (tem-
perature 22 °C, 12 hour light/dark cycle). Twelve mice received a lab chow diet as a control (Con group). Twenty-
four mice received a HF diet (HF group) containing 60% of energy from fat (SF13-092; Specialty Feeds, Glen 
Forrest, WA). After 8 weeks, the twenty-four mice fed a HF diet were divided into two groups: twelve mice 
continued to be fed the HF diet, and the other twelve mice were fed this diet with the addition of 0.5% teasapo-
nin60 (HF + TS group) for 6 weeks. Teasaponin (96%, C57H90O26, MW = 1200) was purchased from the Aladdin 
Chemistry Co. Ltd, China. Body weight was measured on the last day in every week. Food intake was recorded 
on the first day in every week. A weighed amount of fresh diet was given at the beginning of the dark cycle. The 
remaining food in the cage plus spillage were collected and weighed 24 hours later. After 6 weeks of treatment, 
the novel object recognition test and intraperitoneal glucose tolerance test (IPGTT described below) were carried 
out. All mice were asphyxiated in chambers prefilled with CO2 four days after the tests were carried out. Plasma, 
cecal contents, colon tissue and hippocampus tissues were collected, snap frozen and stored at −80 °C for further 
analyses as detailed below. The study was approved by the University of Wollongong Animal Ethics Committee 
(AE13/11) and all animal experiments were conducted in compliance with the National Health and Medical 
Research Council Australian, Code of Practice for the Care and Use of Animals for Scientific Purposes (2004).
Real-time PCR (qRT-PCR) to quantify microbial species from cecal content. DNA from 
cecal contents were extracted by the QIAamp DNA Stool Minikit (QIAGEN, Germany) according to the 
manufacturer’s instructions. Group-specific primers based on 16S rDNA sequences PCR assay were for-
ward Bacteroides-Prevotella, GAGAGGAAGGTCCCCCAC; reverse Bacteroides-Prevotella, CGCTACTTG 
GCTGGTTCAG; forward Desulfovibrios, CCGTAGATATCTGGAGGAACATCAG; reverse Desulfovibrios, 
ACATCTAGCATCCATCGTTTACAGC; forward Lactobacillus, GAGGCAGCAGTAGGGAATCTTC; reverse 
Lactobacillus, GGCCAGTTACTACCTCTATCCTTCTTC; forward Bifidobacterium, CGCGTCTGGTGTGAAAG; 
reverse Bifidobacterium, CCCCACATCCAGCATCCA. Quantitative real-time PCR was performed in a 20-μL 
final reaction volume using a SYBR green I master in a Lightcycler 480 (F. Hoffmann-La Roche Ltd, Switzerland). 
Amplification was carried out with 40 cycles of 95 °C for 5 seconds, 60 °C for 10 seconds, and 72 °C for 10 seconds. 
Each assay was performed in duplicate in the same run. The level of expression for each gene was calculated using the 
comparative threshold cycle value (Ct) method, using the formula 2−ΔΔCt (where ΔΔCt = ΔCt sample–ΔCt refer-
ence). The final results were expressed as normalized fold values relative to the normal group as described previously61.
Lipopolysaccharide (LPS) determination. The concentration of plasma LPS was measured by 
enzyme-linked immunosorbent assay (LAL assay kit, Hycult Biotech, The Netherlands). The absorbance at 405 nm 
was measured with a spectrophotometer. The measurable concentration ranges was from 0.04 to 10 EU/ml. All 
samples for LPS measurements were performed in duplicate.
Western blotting. Hippocampi were dissected and homogenized in NP-40 lysis buffer. The following anti-
bodies were used: MyD88 (1:1000 dilution; sc-74532), NFκB (1:1000 dilution; sc-7178), p-JNK (1:1000 dilu-
tion; sc-81502), IL-1β (1:1000 dilution; sc-7884), BDNF (1:1000 dilution; sc-20981) and IL-6 (1:1000 dilution; 
sc-7920) all purchased from Santa Cruz Biotechnology (Santa Cruz, CA); TNF-α (1:1000 dilution; #11948) and 
TLR4 (1:1000 dilution; #2219) were purchased from Cell Signaling Technology (Beverly, MA). The bands corre-
sponding to the proteins of interest were scanned and band densities were analyzed using the automatic imaging 
analysis system, Quantity One (Bio-Rad Laboratories, Hercules, CA). All quantitative analyses were compared 
with the control group.
Immunohistochemistry. As described previously62, fixed colon tissues were sectioned at 5 µm and incu-
bated overnight at 4 °C with primary antibodies. Sections were then incubated consecutively with secondary 
antibodies for 2 hours at room temperature. The sections were then washed and incubated with streptavidin-HRP 
polymer conjugate (Sigma-Aldrich, Sydney, Australia). The sections were then washed and developed using the 
ImmPACT DAB peroxidase substrate kit (Vector laboratories Inc., Burlingame, USA) and counterstained with 
haematoxylin (POCD Scientific, Artarmon, Australia). Six fields from three sections of each mouse were cap-
tured. The immunohistochemical staining F4/80, CD11c, and CD206 were quantified as a percentage of positive 
area per image by Image J software. The immunoreactivity is quantified as the percentage of pixels in an area of 
interest that have intensity greater than the background.
Fixed hippocampus tissues were sectioned at 35 µm. The sections were washed 3 times with Tris-Buffered 
Saline (TBS) for 10 minutes, and then washed in 1% H2O2 in phosphate buffer saline (PBS) for 30 minutes. After 
three washings with PBS for 5 minutes, the sections were blocked with 5% normal horse serum for 1 hour and 
incubated overnight at 4 °C with primary antibodies. Then sections were washed 3 times with PBS and Tween 
20 (PBST) and incubated consecutively with secondary antibodies for 2 hours at room temperature. The sections 
were then washed and incubated with streptavidin-HRP polymer conjugate (Sigma-Aldrich Pty. Ltd, Sydney, 
Australia) for 1 hour at room temperature. The sections were then washed and developed using the ImmPACT 
DAB peroxidase substrate kit. Six fields from three sections of each mouse were viewed under a Leica micro-
scope and digital photographs were captured. Iba1 and GFAP were used to evaluate the activated phenotype of 
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microglia and astrocytes according to Iba1 and GFAP positive staining and cell morphology. Positive cells were 
manually counted using Photoshop (Adobe).
Novel object recognition test. Recognition memory was assessed by performing a novel object recogni-
tion test based on our group’s previous studies5. Briefly, mice received a 5 minutes habituation in an empty open 
field arena (a white open-field square box, 55 cm × 55 cm × 35 cm). During the training session, two identical 
objects (A) were placed at opposing corners of the box, 5 cm from the adjacent wall. Each mouse was then placed 
in the middle of the open-field box and left to explore the objects for 5 minutes, and the percentage of time spent 
exploring the two identical objects in the open-field box was calculated (time spent on the two identical objects 
divided by 5 minutes). For the retention session, one familiar object (A) was replaced with one novel object (B) 
and measurements were taken according to how much time each mouse spent at each object as per the training 
session. Following a 90-minute inter-trial interval, we returned mice to explore for another 5 minutes. Novel 
object exploration time and the discrimination index (DI = [(Novel Object Exploration Time/Total Exploration 
Time) − (Familiar Object Exploration Time/Total Exploration Time)] × 100) were used to evaluate the recogni-
tion memory of the mice63.
Intraperitoneal glucose tolerance test. All mice were fasted overnight before a glucose tolerance test was 
performed to assess glucose clearance, following an intraperitoneal injection of glucose (0.5 g/kg; Sigma-Aldrich, 
St Louis, MO, USA). Blood samples were taken from the tail vein at 0, 15, 30, 60 and 120 minutes following the 
injection of glucose. Blood glucose was measured using an Accu-Chek glucometer (Roche Diagnostics GmbH 
Mannheim, Germany).
Statistical analysis. The statistical package SPSS 20 (SPSS, Chicago, IL) was used to analyze data. Data 
was first tested for normality before differences among the Con, HF and HF + TS groups were determined using 
one-way analysis of variance (ANOVA). This was followed by the post hoc Tukey-Kramer honestly significant 
difference (HSD) test for multiple comparisons among the groups. A p value of <0.05 was considered to be 
statistically significant. Values were expressed as mean ± SEM. Pearson’s correlations were used to examine the 
relationship between the discrimination index in the novel object recognition test and plasma LPS and BDNF 
levels in the hippocampus.
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